Drug intelligence / Profile preview

Suerox

Development stage: Unknown
Lead developer: Genomma Lab
Modality: Small Molecules
Administration: Oral

Overview

Suerox is an over-the-counter (OTC) oral rehydration solution (ORS) developed and marketed by Genomma Lab Internacional. It is formulated as a sugar-free hydration beverage designed to replenish water and essential electrolytes lost through physical activity, heat exposure, or illness. The product contains a balance of ions, including sodium, potassium, magnesium, and chloride, which are critical for maintaining osmotic pressure and supporting cellular functions. Suerox is positioned both as a functional sports drink for athletes and as a medical-grade electrolyte replacement solution for general consumer use. It is a key part of Genomma Lab's premium branded OTC portfolio and is widely available in Latin American and North American markets.

Brand names: Suerox
Other names: Suerox Genomma Lab

Beyond the preview

Go deeper on Suerox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suerox.

Explore the full profile